In nonsmall cell lung cancer cells, reduced CEMIP suppresses proliferation and migration of nonsmall cell lung cancer cells and down-regulated the expression of several transcription factors related to the EMT process and EGFR signaling.[48]. The gene discussed is CEMIP; the disease is lung cancer.